Peptide corresponding to the C terminus of tissue factor pathway inhibitor inhibits mesangial cell proliferation and activation in vivo

Peptides

Volumn 30, Issue 12, 2009, Pages 2330-2336

  Liang, Wang ^a   Cheng, Juan ^b   Liu, Rui ^a   Wang, Ji ping ^a   Mu, Jin gui ^a   Wang, Qing hua ^c   Wang, Hui jun ^b   Ma, Duan ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti proliferation; Apoptosis; C terminus; Mesangial cell; Proliferative glomerulonephritis; TFPI

Indexed keywords

MALTOSE BINDING PROTEIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL CULTURE; MALE; MESANGIUM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RAT;

AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; LIPOPROTEINS; MALE; MESANGIAL CELLS; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; SEQUENCE HOMOLOGY, AMINO ACID;

RATTUS;

EID: 70449634935     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.08.016     Document Type: Article

References (30)

1. Bagchus W.M., Jeunink M.F., and Elema J.D. The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macromolecular accumulation. Am J Pathol 137 (1990) 215-223
2. Bai H., Ma D., Zhang Y.G., et al. Molecular design and characterization of recombinant long half-life mutants of human tissue factor pathway inhibitor. Thromb Haemost 93 (2005) 1055-1060
3. Baker A.J., Mooney A., Hughes J., et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94 (1994) 2105-2116
4. Chen G., Guo M., and Zhang y.-e. Preparation of anti-Thy1 serum and establishment of mesangioproliferative glomerulonephritis model in rat. J Clin Exp Pathol 12 (1996) 241-243
5. Cunningham M.A., Ono T., Hewitson T.D., et al. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int 55 (1999) 1311-1318
6. El-Nahas A.M. Plasticity of kidney cells: role in kidney remodeling and scarring. Kidney Int 64 (2003) 1553-1563
7. Erlich J.H., Apostolopoulos J., Wun T.C., et al. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 98 (1996) 325-335
8. Gómez-Guerrero C., Hernández-Vargas P., López-Franco O., et al. Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches. Curr Drug Targets Inflamm Allergy 4 (2005) 341-351
9. Hamuro T., Kamikubo Y., Nakahara Y., et al. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Lett 421 (1998) 197-202
10. Hembrough T.A., Ruiz J.F., Swerdlow B.M., et al. Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity. Blood 103 (2004) 3374-3380
11. Herrera G.A. Plasticity of mesangial cells: a basis for understanding pathological alterations. Ultrastruct Pathol 30 (2006) 471-479
12. Hertig A., and Rondeau E. Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol 15 (2004) 844-853
13. Jia H., Qi X., Fang S., et al. Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression. Regul Pept 154 (2009) 69-76
14. Johnson R.J., Floege J., Yoshimura A., et al. The activated mesangial cell: a glomerular "myofibroblast"?. J Am Soc Nephrol 2 (1992) S190-S197
15. Johnson R.J., Iida H., Alpers C.E., et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87 (1991) 847-858
16. Ka S.M., Cheng C.W., Shui H.A., et al. Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Res Ther 9 (2007) R67
17. Kamikubo Y., Nakahara Y., Takemoto S., et al. Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells. FEBS Lett 407 (1997) 116-120
18. Kumar M., Hunag Y., Glinka Y., et al. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Gene Ther 14 (2007) 162-172
19. Kumasaka R., Nakamura N., Fujita T., et al. Beneficial effect of neutrophil elastase inhibitor on anti-Thy1 1 nephritis in rats. Nephrology (Carlton) 13 (2008) 27-32
20. Lin Y.F., Zhang N., Guo H.S., et al. Recombinant tissue factor pathway inhibitor induces apoptosis in cultured rat mesangial cells via its Kunitz-3 domain and C-terminal through inhibiting PI3-kinase/Akt pathway. Apoptosis 12 (2007) 2163-2173
21. Lizakowski S., Zdrojewski Z., Jagodzinski P., et al. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis. Scand J Urol Nephrol 41 (2007) 237-242
22. Naumnik B., Borawski J., Chyczewski L., et al. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis-immunostaining vs plasma and urinary levels. Nephrol Dial Transplant 21 (2006) 3450-3457
23. Nomura K., Liu N., Nagai K., et al. Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis. Lab Invest 87 (2007) 150-160
24. Patel K., Harding P., Haney L.B., et al. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization. J Cell Physiol 195 (2003) 435-445
25. Poncelet A.C., and Schnaper H.W. Regulation of human mesangial cell collagen expression by transforming growth factor-β1. Am J Physiol 275 (1998) F458-466
26. Schocklmann H.O., Lang S., and Sterzel R.B. Regulation of mesangial cell proliferation. Kidney Int 56 (1999) 1199-1207
27. Shirotani-Ikejima H., Kokame K., Hamuro T., et al. Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs. Biochem Biophys Res Commun 299 (2002) 847-852
28. Tamouza H., Vende F., Tiwari M., et al. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy. Contrib Nephrol 157 (2007) 144-147
29. Tokuyama H., Kelly D.J., Cox A., et al. Tranilast ameliorates experimental mesangial proliferative glomerulonephritis. Nephron Exp Nephrol 109 (2008) e1-7
30. Watson S., Cailhier J.F., Hughes J., et al. Apoptos is and glomerulonephritis. Curr Dir Autoimmun 9 (2006) 188-204